SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Unleash Jugs

JUGS is capturing community attention as a new, low-holder crypto asset that speculators believe is primed for a potential squeeze due to high concentration among top addresses. Investors are actively discussing the coin's rapid price volatility and aggressive promotional campaigns, framing it as a high-risk, high-reward play.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEAR is trending as investors focus on its integration into the AI agentic economy and its recent transition toward a lower token inflation model. The community is actively debating the coin's potential as a long-term utility play, with many participants using market dips to accumulate positions while monitoring cross-chain interoperability developments.

Exchange Traded Concepts Trust - ROBO Global Robotics and Automation Index ETF

Exchange Traded Concepts Trust - ETCT ROBO Global Robotics and Automation Index ETF

The ROBO Global Robotics and Automation Index ETF is drawing significant investor interest as it hits new all-time highs, driven by widespread enthusiasm for the rapid advancement of humanoid robotics and embodied AI. Community discussions reflect a strong belief in the long-term secular growth of the sector, with many investors actively accumulating the fund as a strategic hedge and core holding for the rise of automation.

Global X Funds - Global X Funds Global X Robotics & Artificial Intelligence ETF

Global X Funds Global X Robotics & Artificial Intelligence ETF

The BOTZ ETF is capturing significant attention as investors bet on the expanding role of AI and robotics in global supply chains and industrial efficiency. The community is actively discussing its potential for long-term growth while debating the impact of its heavy tech-sector concentration and recent performance within the broader market rotation.

Harmonic, Inc. engages in the development and sale of video delivery software, products, system solutions, and services. It operates through the Video and Broadband segments. The Video segment sells video processing and production and playout services to cable operators, satellite and telecommunications pay-TV service providers, and broadcast and media companies. The Broadband segment offers solutions to cable operators broadband access solutions and related services, including cOS software-based broadband access solution, to broadband operators globally. The company was founded in June 1988 and is headquartered in San Jose, CA.

Harmonic, Inc.

Harmonic, Inc. is trending as investors and high-profile social media accounts track its potential for a structural re-rating driven by a shift from hardware-heavy broadband infrastructure to a recurring software-defined model. While bulls point to strong backlog growth and improved margins, the community is actively debating whether the stock is a long-term compounder or if it is currently overextended and vulnerable to a sharp correction.

What is the project about? Pepe is a community based meme token surround the iconic meme Pepe the frog. Pepe aims to leverage the power of such an iconic meme to become the most memeable memecoin in existence.   What makes your project unique? Pepe is here to make memecoins great again. Ushering in a new paradigm for memecoins, Pepe represents the memecoin in it's purest simplicity. With zero taxes, liquidity locked forever, and contract immutable, Pepe is for the people, forever. Pepe is about culture, rallying together a community to have fun and enjoy memes, fueled purely by memetic power.   History of your project. Pepe was stealth launched on Friday, April 14th, 2023.   What’s next for your project? Pepe will focus on developing a tight-knit community around the token and building resources to enrich the communities knowledge and success in crypto through a token gated group, newsletter, and more tools.   What can your token be used for? Pepe can be used to speculate on the power of memes, and does not pretend to be anything more.

Pepe

Pepe is experiencing high volatility as investors debate its potential for future growth against broader market concerns and meme sector competition. Community discussion is currently dominated by conflicting views on the token's long-term utility versus its speculative nature.

Allegro MicroSystems, Inc. engages in the development and manufacture of sensor integrated circuits (“ICs”) and application-specific analog power ICs. Its sensor ICs enable customers to precisely measure motion, speed, position and current, while its power ICs include high-temperature and high-voltage capable motor driver, power management and light emitting diode driver ICs. The company was founded on March 30, 2013 and is headquartered in Manchester, NH.

Allegro Microsystems Inc.

Allegro MicroSystems is currently drawing significant investor attention due to its strong positioning in the semiconductor industry, despite concerns surrounding cyclicality and supply chain vulnerabilities. The community is actively debating the stock's technical price action and growth potential in sectors like electric vehicles and AI-driven infrastructure.

Direxion Shares ETF Trust - Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 2X ETF

Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 2X Shares

GUSH is trending as investors aggressively position for potential supply shocks following escalating tensions and military activity in the Middle East. The community is sharply divided, with bulls betting on sustained price spikes due to regional instability while bears argue that current events are already priced in or that the conflict will be resolved quickly.

Alcoa Corp. engages in the bauxite mining, alumina refining, and aluminum smelting and casting. It operates through the Alumina and Aluminum segments. The Alumina segment consists of a refining system, including the mining of bauxite, which is then refined into alumina, a compound of aluminum and oxygen that is the raw material used by smelters to produce aluminum metal. The Aluminum segment is composed of smelting and casthouse system. The company was founded by Charles Martin Hall on July 9, 1886 and is headquartered in Pittsburgh, PA.

Alcoa Corp

Alcoa is capturing investor interest as it navigates significant supply chain headwinds and structural tariff costs, while the community actively debates whether the stock is an undervalued industrial play or a value trap. Discussion is currently centered on how the company's asset utilization, including potential site conversions for data centers, balances against ongoing volatility in aluminum pricing and global geopolitical trade pressures.

ETF Series Solutions - Defiance Quantum ETF

Defiance Quantum ETF

Quantum computing stocks are experiencing intense investor interest and volatility driven by reports of significant government investment aimed at accelerating the sector's development. While retail sentiment remains highly enthusiastic about the long-term potential for massive growth, many traders are turning to the Defiance Quantum ETF (QTUM) to gain diversified exposure to the space rather than attempting to navigate the high risks associated with individual quantum companies.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BIIB Advances Alzheimer's Disease Drug Despite Study Missing Main Goal

Biogen advances Alzheimer's drug diranersen to late-stage trials after a phase II study misses its main goal but shows cognitive and biomarker gains.

Ionis partner Biogen announces topline results from Phase 2 CELIA study of diranersen (BIIB080): first study to show reduction in tau pathology and cognitive benefit in patients with early Alzheimers disease

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that its partner, Biogen, shared compelling topline results from the Phase 2 CELIA study evaluating diranersen (IONIS-MAPTRx/BIIB080), an...

Tweedy Browne Co LLC Decreases Stock Holdings in Ionis Pharmaceuticals, Inc. $IONS

Tweedy Browne Co LLC lowered its stake in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) by 15.0% during the fourth quarter, according to the company in its most recent filing with...

Ionis to host 2026 virtual Annual Meeting of Stockholders

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will conduct its 2026 virtual Annual Meeting of Stockholders followed by a general corporate update on Thursday, June 4...

What is HC Wainwright's Estimate for IONS Q1 Earnings?

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) - Equities research analysts at HC Wainwright issued their Q1 2027 earnings per share estimates for Ionis Pharmaceuticals in a report released on Thursday, April 30th. HC Wainwright analyst M. Kapoor anticipates that the company will post earni...

Kornitzer Capital Management Inc. KS Buys Shares of 29,105 Ionis Pharmaceuticals, Inc. $IONS

Kornitzer Capital Management Inc. KS bought a new stake in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) during the fourth quarter, according to its most recent filing with the Securities...

Ionis Pharmaceuticals (NASDAQ:IONS) Stock Rating Upgraded by Wall Street Zen

Wall Street Zen upgraded shares of Ionis Pharmaceuticals from a "strong sell" rating to a "hold" rating in a research report on Saturday...

Vanguard Group Inc. Sells 41,271 Shares of Ionis Pharmaceuticals, Inc. $IONS

Vanguard Group Inc. decreased its stake in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) by 0.3% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 16,440,459 shares of the company's...

Ionis to present at upcoming investor conferences

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in fireside chats at the following investor conferences: Bank of America Securities 2026 Health Care...

Ionis Pharmaceuticals (NASDAQ:IONS) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says

Royal Bank Of Canada upped their target price on shares of Ionis Pharmaceuticals from $95.00 to $100.00 and gave the company an "outperform" rating in a report on Thursday...

Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia on January 10, 1989 and is headquartered in Carlsbad, CA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	-$1.06	--	--	N/A
Q1 '26	-$0.88	-$0.56	36.11%	BEAT
Q4 '25	-$1.31	-$1.41	-7.35%	MISSED
Q3 '25	-$1.22	-$0.80	34.33%	BEAT
Q2 '25	-$0.09	$0.70	868.38%	BEAT

IONS
Ionis Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q1 '26

Historical Earnings

Compact View

Latest IONS News

IONSIonis Pharmaceuticals Inc